APO Research
Talk to an analyst

APO RESEARCH · REPORT

Value-based Healthcare Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Value-based Healthcare Service Market Outlook and Growth Opportunities 2026

5 March 2026216 pages

Choose your research edition.

Industry ResearchValue-based Healthcare Service Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Value-based Healthcare Service Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Value-based Healthcare Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Value-based Healthcare Service Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Value-based Healthcare Service Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Value-based Healthcare Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Value-based Healthcare Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Value-based Healthcare Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Value-based Healthcare Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Value-based Healthcare Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Value-based Healthcare Service market include UnitedHealth Group, Optum, CVS Health, Humana, Kaiser Permanente, Intermountain Health, Mayo Clinic, Cleveland Clinic and Ascension Health, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Value-based Healthcare Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Value-based Healthcare Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Value-based Healthcare Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Value-based Healthcare Service market.

Value-based Healthcare Service Segment by Company

UnitedHealth Group

Optum

CVS Health

Humana

Kaiser Permanente

Intermountain Health

Mayo Clinic

Cleveland Clinic

Ascension Health

HCA Healthcare

Tenet Healthcare

Cigna

Aetna

Elevance Health

Blue Cross Blue Shield Association

NHS England

Ramsay Health Care

Bupa

Teladoc Health

Ping An Healthcare

Alibaba Health

WeDoctor

Value-based Healthcare Service Segment by Type

Bundled Payment

Capitation

Outcome-Based Payment

Shared Savings Model

Value-based Healthcare Service Segment by Application

Corporate Insured

Public Insurance

Others

Value-based Healthcare Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Value-based Healthcare Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Value-based Healthcare Service key companies, revenue, market share, and recent developments.

3. To split the Value-based Healthcare Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Value-based Healthcare Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Value-based Healthcare Service significant trends, drivers, influence factors in global and regions.

6. To analyze Value-based Healthcare Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Value-based Healthcare Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Value-based Healthcare Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Value-based Healthcare Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Value-based Healthcare Service industry.

Chapter 3: Detailed analysis of Value-based Healthcare Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Value-based Healthcare Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Value-based Healthcare Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Value-based Healthcare Service Industry Trends Table 2. Value-based Healthcare Service Industry Drivers Table 3. Value-based Healthcare Service Industry Opportunities and Challenges Table 4. Value-based Healthcare Service Industry Restraints Table 5. Global Value-based Healthcare Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Value-based Healthcare Service Revenue Share by Company (2021-2026) Table 7. Global Value-based Healthcare Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Value-based Healthcare Service Key Company Manufacturing Base & Headquarters Table 9. Global Value-based Healthcare Service Company, Product Type & Application Table 10. Global Value-based Healthcare Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Value-based Healthcare Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Bundled Payment Table 15. Significant Companies of Capitation Table 16. Significant Companies of Outcome-Based Payment Table 17. Significant Companies of Shared Savings Model Table 18. Global Value-based Healthcare Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Value-based Healthcare Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Value-based Healthcare Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Value-based Healthcare Service Sales Value Share by Type (2021-2026) Table 22. Global Value-based Healthcare Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Corporate Insured Table 24. Significant Companies of Public Insurance Table 25. Significant Companies of Others Table 26. Global Value-based Healthcare Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Value-based Healthcare Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Value-based Healthcare Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Value-based Healthcare Service Sales Value Share by Application (2021-2026) Table 30. Global Value-based Healthcare Service Sales Value Share by Application (2027-2032) Table 31. Global Value-based Healthcare Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Value-based Healthcare Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Value-based Healthcare Service Sales Value Share by Region (2021-2026) Table 34. Global Value-based Healthcare Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Value-based Healthcare Service Sales Value Share by Region (2027-2032) Table 36. Global Value-based Healthcare Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Value-based Healthcare Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Value-based Healthcare Service Sales Value Market Share by Country (2021-2026) Table 39. Global Value-based Healthcare Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Value-based Healthcare Service Sales Value Market Share by Country (2027-2032) Table 41. UnitedHealth Group Company Information Table 42. UnitedHealth Group Business Overview Table 43. UnitedHealth Group Value-based Healthcare Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. UnitedHealth Group Value-based Healthcare Service Product Portfolio Table 45. UnitedHealth Group Recent Development Table 46. Optum Company Information Table 47. Optum Business Overview Table 48. Optum Value-based Healthcare Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Optum Value-based Healthcare Service Product Portfolio Table 50. Optum Recent Development Table 51. CVS Health Company Information Table 52. CVS Health Business Overview Table 53. CVS Health Value-based Healthcare Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. CVS Health Value-based Healthcare Service Product Portfolio Table 55. CVS Health Recent Development Table 56. Humana Company Information Table 57. Humana Business Overview Table 58. Humana Value-based Healthcare Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Humana Value-based Healthcare Service Product Portfolio Table 60. Humana Recent Development Table 61. Kaiser Permanente Company Information Table 62. Kaiser Permanente Business Overview Table 63. Kaiser Permanente Value-based Healthcare Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Kaiser Permanente Value-based Healthcare Service Product Portfolio Table 65. Kaiser Permanente Recent Development Table 66. Intermountain Health Company Information Table 67. Intermountain Health Business Overview Table 68. Intermountain Health Value-based Healthcare Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Intermountain Health Value-based Healthcare Service Product Portfolio Table 70. Intermountain Health Recent Development Table 71. Mayo Clinic Company Information Table 72. Mayo Clinic Business Overview Table 73. Mayo Clinic Value-based Healthcare Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Mayo Clinic Value-based Healthcare Service Product Portfolio Table 75. Mayo Clinic Recent Development Table 76. Cleveland Clinic Company Information Table 77. Cleveland Clinic Business Overview Table 78. Cleveland Clinic Value-based Healthcare Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Cleveland Clinic Value-based Healthcare Service Product Portfolio Table 80. Cleveland Clinic Recent Development Table 81. Ascension Health Company Information Table 82. Ascension Health Business Overview Table 83. Ascension Health Value-based Healthcare Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Ascension Health Value-based Healthcare Service Product Portfolio Table 85. Ascension Health Recent Development Table 86. HCA Healthcare Company Information Table 87. HCA Healthcare Business Overview Table 88. HCA Healthcare Value-based Healthcare Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. HCA Healthcare Value-based Healthcare Service Product Portfolio Table 90. HCA Healthcare Recent Development Table 91. Tenet Healthcare Company Information Table 92. Tenet Healthcare Business Overview Table 93. Tenet Healthcare Value-based Healthcare Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Tenet Healthcare Value-based Healthcare Service Product Portfolio Table 95. Tenet Healthcare Recent Development Table 96. Cigna Company Information Table 97. Cigna Business Overview Table 98. Cigna Value-based Healthcare Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Cigna Value-based Healthcare Service Product Portfolio Table 100. Cigna Recent Development Table 101. Aetna Company Information Table 102. Aetna Business Overview Table 103. Aetna Value-based Healthcare Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Aetna Value-based Healthcare Service Product Portfolio Table 105. Aetna Recent Development Table 106. Elevance Health Company Information Table 107. Elevance Health Business Overview Table 108. Elevance Health Value-based Healthcare Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Elevance Health Value-based Healthcare Service Product Portfolio Table 110. Elevance Health Recent Development Table 111. Blue Cross Blue Shield Association Company Information Table 112. Blue Cross Blue Shield Association Business Overview Table 113. Blue Cross Blue Shield Association Value-based Healthcare Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Blue Cross Blue Shield Association Value-based Healthcare Service Product Portfolio Table 115. Blue Cross Blue Shield Association Recent Development Table 116. NHS England Company Information Table 117. NHS England Business Overview Table 118. NHS England Value-based Healthcare Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. NHS England Value-based Healthcare Service Product Portfolio Table 120. NHS England Recent Development Table 121. Ramsay Health Care Company Information Table 122. Ramsay Health Care Business Overview Table 123. Ramsay Health Care Value-based Healthcare Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Ramsay Health Care Value-based Healthcare Service Product Portfolio Table 125. Ramsay Health Care Recent Development Table 126. Bupa Company Information Table 127. Bupa Business Overview Table 128. Bupa Value-based Healthcare Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Bupa Value-based Healthcare Service Product Portfolio Table 130. Bupa Recent Development Table 131. Teladoc Health Company Information Table 132. Teladoc Health Business Overview Table 133. Teladoc Health Value-based Healthcare Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Teladoc Health Value-based Healthcare Service Product Portfolio Table 135. Teladoc Health Recent Development Table 136. Ping An Healthcare Company Information Table 137. Ping An Healthcare Business Overview Table 138. Ping An Healthcare Value-based Healthcare Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Ping An Healthcare Value-based Healthcare Service Product Portfolio Table 140. Ping An Healthcare Recent Development Table 141. Alibaba Health Company Information Table 142. Alibaba Health Business Overview Table 143. Alibaba Health Value-based Healthcare Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Alibaba Health Value-based Healthcare Service Product Portfolio Table 145. Alibaba Health Recent Development Table 146. WeDoctor Company Information Table 147. WeDoctor Business Overview Table 148. WeDoctor Value-based Healthcare Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. WeDoctor Value-based Healthcare Service Product Portfolio Table 150. WeDoctor Recent Development Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Value-based Healthcare Service Product Image Figure 2. Global Value-based Healthcare Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Value-based Healthcare Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Value-based Healthcare Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Bundled Payment Image Figure 8. Capitation Image Figure 9. Outcome-Based Payment Image Figure 10. Shared Savings Model Image Figure 11. Global Value-based Healthcare Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Value-based Healthcare Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Value-based Healthcare Service Sales Value Share by Type (2021-2032) Figure 14. Corporate Insured Image Figure 15. Public Insurance Image Figure 16. Others Image Figure 17. Global Value-based Healthcare Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Value-based Healthcare Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Value-based Healthcare Service Sales Value Share by Application (2021-2032) Figure 20. Global Value-based Healthcare Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Value-based Healthcare Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Value-based Healthcare Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America Value-based Healthcare Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Value-based Healthcare Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Value-based Healthcare Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Value-based Healthcare Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Value-based Healthcare Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Value-based Healthcare Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America Value-based Healthcare Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Value-based Healthcare Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Value-based Healthcare Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Value-based Healthcare Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Bundled Payment
  • Capitation
  • Outcome-Based Payment
  • Shared Savings Model
Applications
  • Corporate Insured
  • Public Insurance
  • Others
Companies covered
  • UnitedHealth Group
  • Optum
  • CVS Health
  • Humana
  • Kaiser Permanente
  • Intermountain Health
  • Mayo Clinic
  • Cleveland Clinic
  • Ascension Health
  • HCA Healthcare
  • Tenet Healthcare
  • Cigna
  • Aetna
  • Elevance Health
  • Blue Cross Blue Shield Association
  • NHS England
  • Ramsay Health Care
  • Bupa
  • Teladoc Health
  • Ping An Healthcare
  • Alibaba Health
  • WeDoctor

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Value-based Healthcare Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Value-based Healthcare Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Value-based Healthcare Service Market Dynamics
  1. 2.1 Value-based Healthcare Service Industry Trends
  2. 2.2 Value-based Healthcare Service Industry Drivers
  3. 2.3 Value-based Healthcare Service Industry Opportunities and Challenges
  4. 2.4 Value-based Healthcare Service Industry Restraints
3 Value-based Healthcare Service Market by Company
  1. 3.1 Global Value-based Healthcare Service Company Revenue Ranking in 2025
  2. 3.2 Global Value-based Healthcare Service Revenue by Company (2021-2026)
  3. 3.3 Global Value-based Healthcare Service Company Ranking (2024-2026)
  4. 3.4 Global Value-based Healthcare Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Value-based Healthcare Service Company Product Type and Application
  6. 3.6 Global Value-based Healthcare Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Value-based Healthcare Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Value-based Healthcare Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Value-based Healthcare Service Market by Type
  1. 4.1 Value-based Healthcare Service Type Introduction
  2. 4.1.1 Bundled Payment
  3. 4.1.2 Capitation
  4. 4.1.3 Outcome-Based Payment
  5. 4.1.4 Shared Savings Model
  6. 4.2 Global Value-based Healthcare Service Sales Value by Type
  7. 4.2.1 Global Value-based Healthcare Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Value-based Healthcare Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Value-based Healthcare Service Sales Value Share by Type (2021-2032)
5 Value-based Healthcare Service Market by Application
  1. 5.1 Value-based Healthcare Service Application Introduction
  2. 5.1.1 Corporate Insured
  3. 5.1.2 Public Insurance
  4. 5.1.3 Others
  5. 5.2 Global Value-based Healthcare Service Sales Value by Application
  6. 5.2.1 Global Value-based Healthcare Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Value-based Healthcare Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Value-based Healthcare Service Sales Value Share by Application (2021-2032)
6 Value-based Healthcare Service Regional Value Analysis
  1. 6.1 Global Value-based Healthcare Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Value-based Healthcare Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Value-based Healthcare Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Value-based Healthcare Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Value-based Healthcare Service Sales Value (2021-2032)
  7. 6.3.2 North America Value-based Healthcare Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Value-based Healthcare Service Sales Value (2021-2032)
  10. 6.4.2 Europe Value-based Healthcare Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Value-based Healthcare Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Value-based Healthcare Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Value-based Healthcare Service Sales Value (2021-2032)
  16. 6.6.2 South America Value-based Healthcare Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Value-based Healthcare Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Value-based Healthcare Service Sales Value Share by Country, 2025 VS 2032
7 Value-based Healthcare Service Country-level Value Analysis
  1. 7.1 Global Value-based Healthcare Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Value-based Healthcare Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Value-based Healthcare Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Value-based Healthcare Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Value-based Healthcare Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Value-based Healthcare Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Value-based Healthcare Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 UnitedHealth Group
  2. 8.1.1 UnitedHealth Group Company Information
  3. 8.1.2 UnitedHealth Group Business Overview
  4. 8.1.3 UnitedHealth Group Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 UnitedHealth Group Value-based Healthcare Service Product Portfolio
  6. 8.1.5 UnitedHealth Group Recent Developments
  7. 8.2 Optum
  8. 8.2.1 Optum Company Information
  9. 8.2.2 Optum Business Overview
  10. 8.2.3 Optum Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Optum Value-based Healthcare Service Product Portfolio
  12. 8.2.5 Optum Recent Developments
  13. 8.3 CVS Health
  14. 8.3.1 CVS Health Company Information
  15. 8.3.2 CVS Health Business Overview
  16. 8.3.3 CVS Health Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CVS Health Value-based Healthcare Service Product Portfolio
  18. 8.3.5 CVS Health Recent Developments
  19. 8.4 Humana
  20. 8.4.1 Humana Company Information
  21. 8.4.2 Humana Business Overview
  22. 8.4.3 Humana Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Humana Value-based Healthcare Service Product Portfolio
  24. 8.4.5 Humana Recent Developments
  25. 8.5 Kaiser Permanente
  26. 8.5.1 Kaiser Permanente Company Information
  27. 8.5.2 Kaiser Permanente Business Overview
  28. 8.5.3 Kaiser Permanente Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kaiser Permanente Value-based Healthcare Service Product Portfolio
  30. 8.5.5 Kaiser Permanente Recent Developments
  31. 8.6 Intermountain Health
  32. 8.6.1 Intermountain Health Company Information
  33. 8.6.2 Intermountain Health Business Overview
  34. 8.6.3 Intermountain Health Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Intermountain Health Value-based Healthcare Service Product Portfolio
  36. 8.6.5 Intermountain Health Recent Developments
  37. 8.7 Mayo Clinic
  38. 8.7.1 Mayo Clinic Company Information
  39. 8.7.2 Mayo Clinic Business Overview
  40. 8.7.3 Mayo Clinic Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mayo Clinic Value-based Healthcare Service Product Portfolio
  42. 8.7.5 Mayo Clinic Recent Developments
  43. 8.8 Cleveland Clinic
  44. 8.8.1 Cleveland Clinic Company Information
  45. 8.8.2 Cleveland Clinic Business Overview
  46. 8.8.3 Cleveland Clinic Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cleveland Clinic Value-based Healthcare Service Product Portfolio
  48. 8.8.5 Cleveland Clinic Recent Developments
  49. 8.9 Ascension Health
  50. 8.9.1 Ascension Health Company Information
  51. 8.9.2 Ascension Health Business Overview
  52. 8.9.3 Ascension Health Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ascension Health Value-based Healthcare Service Product Portfolio
  54. 8.9.5 Ascension Health Recent Developments
  55. 8.10 HCA Healthcare
  56. 8.10.1 HCA Healthcare Company Information
  57. 8.10.2 HCA Healthcare Business Overview
  58. 8.10.3 HCA Healthcare Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 HCA Healthcare Value-based Healthcare Service Product Portfolio
  60. 8.10.5 HCA Healthcare Recent Developments
  61. 8.11 Tenet Healthcare
  62. 8.11.1 Tenet Healthcare Company Information
  63. 8.11.2 Tenet Healthcare Business Overview
  64. 8.11.3 Tenet Healthcare Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Tenet Healthcare Value-based Healthcare Service Product Portfolio
  66. 8.11.5 Tenet Healthcare Recent Developments
  67. 8.12 Cigna
  68. 8.12.1 Cigna Company Information
  69. 8.12.2 Cigna Business Overview
  70. 8.12.3 Cigna Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cigna Value-based Healthcare Service Product Portfolio
  72. 8.12.5 Cigna Recent Developments
  73. 8.13 Aetna
  74. 8.13.1 Aetna Company Information
  75. 8.13.2 Aetna Business Overview
  76. 8.13.3 Aetna Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Aetna Value-based Healthcare Service Product Portfolio
  78. 8.13.5 Aetna Recent Developments
  79. 8.14 Elevance Health
  80. 8.14.1 Elevance Health Company Information
  81. 8.14.2 Elevance Health Business Overview
  82. 8.14.3 Elevance Health Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Elevance Health Value-based Healthcare Service Product Portfolio
  84. 8.14.5 Elevance Health Recent Developments
  85. 8.15 Blue Cross Blue Shield Association
  86. 8.15.1 Blue Cross Blue Shield Association Company Information
  87. 8.15.2 Blue Cross Blue Shield Association Business Overview
  88. 8.15.3 Blue Cross Blue Shield Association Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Blue Cross Blue Shield Association Value-based Healthcare Service Product Portfolio
  90. 8.15.5 Blue Cross Blue Shield Association Recent Developments
  91. 8.16 NHS England
  92. 8.16.1 NHS England Company Information
  93. 8.16.2 NHS England Business Overview
  94. 8.16.3 NHS England Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 NHS England Value-based Healthcare Service Product Portfolio
  96. 8.16.5 NHS England Recent Developments
  97. 8.17 Ramsay Health Care
  98. 8.17.1 Ramsay Health Care Company Information
  99. 8.17.2 Ramsay Health Care Business Overview
  100. 8.17.3 Ramsay Health Care Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Ramsay Health Care Value-based Healthcare Service Product Portfolio
  102. 8.17.5 Ramsay Health Care Recent Developments
  103. 8.18 Bupa
  104. 8.18.1 Bupa Company Information
  105. 8.18.2 Bupa Business Overview
  106. 8.18.3 Bupa Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Bupa Value-based Healthcare Service Product Portfolio
  108. 8.18.5 Bupa Recent Developments
  109. 8.19 Teladoc Health
  110. 8.19.1 Teladoc Health Company Information
  111. 8.19.2 Teladoc Health Business Overview
  112. 8.19.3 Teladoc Health Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Teladoc Health Value-based Healthcare Service Product Portfolio
  114. 8.19.5 Teladoc Health Recent Developments
  115. 8.20 Ping An Healthcare
  116. 8.20.1 Ping An Healthcare Company Information
  117. 8.20.2 Ping An Healthcare Business Overview
  118. 8.20.3 Ping An Healthcare Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Ping An Healthcare Value-based Healthcare Service Product Portfolio
  120. 8.20.5 Ping An Healthcare Recent Developments
  121. 8.21 Alibaba Health
  122. 8.21.1 Alibaba Health Company Information
  123. 8.21.2 Alibaba Health Business Overview
  124. 8.21.3 Alibaba Health Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Alibaba Health Value-based Healthcare Service Product Portfolio
  126. 8.21.5 Alibaba Health Recent Developments
  127. 8.22 WeDoctor
  128. 8.22.1 WeDoctor Company Information
  129. 8.22.2 WeDoctor Business Overview
  130. 8.22.3 WeDoctor Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 WeDoctor Value-based Healthcare Service Product Portfolio
  132. 8.22.5 WeDoctor Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst